Get the Stockscreener App
11.02
0.09%
-0.010
Pre-market:
11.08
0.06
+0.54%
Overview
News
Price History
Option Chain
Financials
Why FMC Down?
Discussions
Forecast
Stock Split
Dividend History
Fmc Corp stock is traded at $11.02, with a volume of 3.36M.
It is down -0.09% in the last 24 hours and down -15.94% over the past month.
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
See More
Previous Close:
$11.03
Open:
$11.16
24h Volume:
3.36M
Relative Volume:
1.01
Market Cap:
$1.38B
Revenue:
$3.43B
Net Income/Loss:
$-2.46B
P/E Ratio:
-0.5505
EPS:
-20.0187
Net Cash Flow:
$-204.10M
1W Performance:
-5.00%
1M Performance:
-15.94%
6M Performance:
-16.07%
1Y Performance:
-74.31%
1-Day Range:
$10.75
$11.27
1-Week Range:
$10.75
$12.67
52-Week Range:
$10.72
$44.68
Fmc Corp Stock (FMC) Company Profile
Name
Fmc Corp
Sector
Industry
Phone
215-299-6668
Address
2929 WALNUT STREET, PHILADELPHIA, PA
Compare FMC vs CTVA, NTR, CF, MOS, ICL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FMC
Fmc Corp
|
11.02 | 1.38B | 3.43B | -2.46B | -204.10M | -20.02 |
CTVA
Corteva Inc
|
79.11 | 52.91B | 17.89B | 1.26B | 2.05B | 1.7029 |
NTR
Nutrien Ltd
|
61.54 | 29.54B | 27.83B | 2.42B | 2.21B | 4.9113 |
CF
Cf Industries Holdings Inc
|
102.17 | 15.70B | 7.41B | 2.12B | 1.62B | 11.13 |
MOS
Mosaic Company
|
21.25 | 6.75B | 12.05B | 575.40M | -534.60M | 1.6871 |
ICL
Icl Group Ltd
|
5.00 | 6.45B | 7.41B | 314.00M | 220.88M | 0.202 |
Fmc Corp Stock (FMC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-22-26 | Downgrade | Vertical Research | Hold → Sell |
| Dec-09-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Nov-11-25 | Resumed | Wells Fargo | Equal Weight |
| Oct-31-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-31-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-30-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-14-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Jun-23-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-25-25 | Upgrade | Mizuho | Neutral → Outperform |
| Mar-13-25 | Initiated | Goldman | Buy |
| Feb-14-25 | Downgrade | Redburn Atlantic | Buy → Neutral |
| Feb-07-25 | Downgrade | UBS | Buy → Neutral |
| Feb-05-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-21-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-14-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-23-24 | Initiated | Citigroup | Neutral |
| Jun-26-24 | Initiated | Barclays | Equal Weight |
| Mar-01-24 | Initiated | Wolfe Research | Peer Perform |
| Feb-12-24 | Downgrade | Loop Capital | Buy → Hold |
| Feb-07-24 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Jan-16-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-04-24 | Initiated | ROTH MKM | Buy |
| Dec-14-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-07-23 | Downgrade | Mizuho | Buy → Neutral |
| Oct-24-23 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-24-23 | Downgrade | Goldman | Buy → Neutral |
| Oct-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-16-23 | Upgrade | Vertical Research | Hold → Buy |
| Sep-25-23 | Downgrade | Redburn Atlantic | Overweight → Neutral |
| Sep-05-23 | Downgrade | UBS | Buy → Neutral |
| Aug-21-23 | Initiated | JP Morgan | Neutral |
| Aug-04-23 | Upgrade | Credit Suisse | Underperform → Neutral |
| Jul-24-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-17-23 | Upgrade | Redburn | Neutral → Buy |
| Jan-19-23 | Resumed | Wells Fargo | Overweight |
| Jan-10-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-15-22 | Upgrade | Loop Capital | Hold → Buy |
| Jul-20-22 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jun-21-22 | Upgrade | BofA Securities | Underperform → Buy |
| Jun-13-22 | Downgrade | Redburn | Buy → Neutral |
| May-31-22 | Initiated | Credit Suisse | Underperform |
| Apr-14-22 | Downgrade | Loop Capital | Buy → Hold |
| Mar-31-22 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| Mar-22-22 | Downgrade | BofA Securities | Buy → Underperform |
| Feb-10-22 | Reiterated | Citigroup | Buy |
| Feb-10-22 | Reiterated | Mizuho | Buy |
| Feb-10-22 | Reiterated | Monness Crespi & Hardt | Buy |
| Feb-10-22 | Reiterated | Wells Fargo | Overweight |
| Jan-31-22 | Initiated | Redburn | Buy |
| Jan-11-22 | Upgrade | Citigroup | Neutral → Buy |
| Nov-29-21 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-18-21 | Upgrade | Loop Capital | Hold → Buy |
| Oct-13-21 | Initiated | Mizuho | Buy |
| Oct-11-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-24-21 | Downgrade | Vertical Research | Buy → Hold |
| May-06-21 | Downgrade | Citigroup | Buy → Neutral |
| Feb-11-21 | Upgrade | Monness Crespi & Hardt | Neutral → Buy |
| Sep-17-20 | Initiated | UBS | Buy |
| Mar-26-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Mar-13-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Oct-16-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-16-19 | Initiated | Wells Fargo | Outperform |
| Sep-18-19 | Initiated | Exane BNP Paribas | Outperform |
| Aug-09-19 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-02-19 | Upgrade | Goldman | Neutral → Buy |
| Aug-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-13-19 | Resumed | Citigroup | Buy |
| May-20-19 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-18-19 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Mar-21-19 | Reiterated | Jefferies | Buy |
| Mar-08-19 | Resumed | Goldman | Neutral |
| Nov-14-18 | Initiated | Buckingham Research | Buy |
| Nov-09-18 | Resumed | Loop Capital | Buy |
| Nov-05-18 | Resumed | Citigroup | Buy |
| Nov-05-18 | Resumed | Credit Suisse | Outperform |
| May-14-18 | Upgrade | Goldman | Neutral → Buy |
| May-04-18 | Upgrade | Stephens | Equal-Weight → Overweight |
View All
Fmc Corp Stock (FMC) Latest News
Authority fungicide from FMC Corp.early corn protection with soil-active mix - Ad-hoc-news.de
FMC (NYSE: FMC) alters credit agreement liens and releases some collateral - Stock Titan
FMC Corp announces $114 million sale-leaseback in Delaware, shares ahead of July earnings - Ad-hoc-news.de
FMC enters into $114M sale-leaseback deal for Newark, Delaware property - MSN
FMC Enters Agreement for Newark Property Sale Worth $114 Million - GuruFocus
Form 8K FMC Corp For: 23 June By Investing.com - Investing.com India
FMC Corporation enters agreement to sell Delaware property for $114 million - Investing.com Canada
FMC to Sell Delaware Property for About $114 Million to Ercor Elkton, Plans Leaseback - TradingView
FMC (NYSE: FMC) plans $114M Delaware campus sale to cut debt - Stock Titan
FMC Corporation Announces $114 Million Sale-Leaseback of Newark, Delaware Property - Yahoo Finance
Favourable Signals For FMC: Numerous Insiders Acquired Stock - Moomoo
FMC Corp (FMC) Institutional Confidence - TradingKey
The Command Insecticide from FMC Corp.herbicide control in early corn growth - AD HOC NEWS
FMC Corp. stock underperforms Monday when compared to competitors - MarketWatch
FMC Corporation announces date for second quarter 2026 earnings release and webcast conference call - Finviz
FMC schedules July 29 earnings release, July 30 webcast call - Stock Titan
FMC Maintains Rating by Citigroup -- Price Target Lowered to $14 - GuruFocus
Citi Maintains FMC Corp(FMC.US) With Hold Rating, Cuts Target Price to $14 - Moomoo
FMC Corp. StockMonday analyst snapshot and outlook - AD HOC NEWS
FMC Corp. Sale Decision Could Come This Summer for Philadelphia Pesticide Giant - PHILADELPHIA.Today
Why FMC’s Authority 3 herbicide is drawing growers’ attention - AD HOC NEWS
FMC Corp. sale decision could come this summer for Philadelphia pesticide giant - MSN
FMC News | FMC CORP (NYSE:FMC) - ChartMill
FMC Corp. stock underperforms Thursday when compared to competitors - MarketWatch
FMC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
FMC, Corteva to partner on herbicide technology supply and license deal - MSN
Quiet but potent, rimisoxafen from FMC puts stubborn weeds under pressure - AD HOC NEWS
FMC and Corteva Partner to Expand Access to Rimisoxafen Technology - Yahoo Finance
BofA Securities Maintains FMC Corp(FMC.US) With Hold Rating, Announces Target Price $19 - Moomoo
FMC Corp. stock outperforms competitors on strong trading day - MarketWatch
FMC boss says the company could be sold by July - Inquirer.com
FMC Up Nearly 9%, on Pace for Largest Percent Increase Since April 2025 -- Data Talk - Moomoo
FMC Corp (FMC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
FMC Corp (FMC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
FMC Corp. and Corteva Expand Access to Breakthrough Rimisoxafen Herbicide Technology - AgriBusiness Global
FMC Corp (FMC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
FMC Corp (FMC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
FMC Corp (FMC) Valuation: PE, PB & Fair Value Analysis - TradingKey
FMC Corp (FMC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
FMC Corp (FMC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
FMC Corp (FMC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
FMC and Corteva Sign Strategic Supply and License Agreement for Rimisoxafen Herbicide Technology - iGrow News
Best Agriculture Stocks to Buy in 2026 - The Motley Fool
FMC Enters Strategic Agreement to Expand Herbicide Technology Ac - GuruFocus
FMC Corp. (FMC) Partners with Corteva to Enhance Herbicide Techn - GuruFocus
FMC, Corteva to partner on herbicide technology supply and license deal (FMC:NYSE) - Seeking Alpha
FMC and Corteva partner on herbicide technology distribution - Investing.com
FMC Corporation and Corteva Expand Access to Breakthrough Rimisoxafen Herbicide Technology - Financial Times
New biological label extension puts FMC’s Exirel insecticide in the spotlight - AD HOC NEWS
FMC (FMC) CEO Brondeau reports tax-withholding of 34,177 vested shares - Stock Titan
FMC Corp. Stock (US3024913036): Valuation Comes Into Focus After Prolonged Downturn - AD HOC NEWS
Fmc Corp Stock (FMC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.02%
3.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):